Can Lorazepam Cause Weight Gain and How to Manage It?

Lorazepam is not strongly linked to weight gain in clinical trials the way some psychiatric medications are, but real-world adverse event data and the drug’s known effects on appetite suggest it can contribute to added pounds in some people. A large pharmacovigilance analysis of FDA reports found obesity flagged as a statistically significant adverse event among lorazepam users, which is not something the drug’s official labeling warns about. The path from lorazepam to extra weight runs through several indirect mechanisms rather than a single straightforward one, and understanding those mechanisms matters if you want to stay ahead of the problem.

What the Adverse Event Data Actually Shows

Lorazepam’s prescribing information does not list weight gain as a common side effect. The label focuses on sedation, dizziness, and the well-known risks of dependence. But a 2024 pharmacovigilance study that mined the FDA Adverse Event Reporting System (FAERS) database turned up something the label misses: 709 reports of obesity among lorazepam users, with a reporting odds ratio above 3, meaning the association was roughly three times higher than you would expect by chance compared to other drugs in the database. The researchers flagged this as an “unexpected significant adverse event” not captured in the current label.

A few caveats are important here. FAERS data is based on voluntary reports, not controlled trials. People who gain weight on a drug may be more inclined to report it when they notice the change, and the database cannot prove that lorazepam caused the weight gain rather than, say, a coexisting condition or another medication. Still, the statistical signal was strong enough and consistent across multiple detection algorithms that the researchers considered it a genuine safety signal worth investigating. It tells us that weight gain is not some rare fluke complaint: hundreds of lorazepam users have reported it to the FDA.

How Lorazepam Can Increase Your Appetite

The most direct route from lorazepam to weight gain runs through your appetite. Benzodiazepines as a class are known to stimulate eating, and researchers have spent decades working out why. The effect is not simply that you feel less anxious and therefore eat more comfortably, though that can play a role. The primary mechanism appears to be that benzodiazepines change how food tastes and feels, making it more rewarding.

Studies in both animals and humans show that benzodiazepines enhance what researchers call “palatability,” the pleasurable quality of food. When you take lorazepam, foods you already enjoy taste even better, and you are more motivated to seek out and consume them. This effect is mediated through specific subtypes of the GABA-A receptor, most likely the alpha-2 and alpha-3 subtypes rather than the alpha-1 subtype responsible for sedation.

This distinction is worth knowing because it means the appetite-boosting effect is pharmacologically separate from the calming effect. You cannot assume that finding the right dose for anxiety relief will also dodge the appetite issue, because the two effects are driven by different receptor populations. Research on rats has confirmed that even in animals with surgically disconnected higher brain regions, benzodiazepines still enhanced taste pleasure through brainstem receptors alone, suggesting the appetite effect is deeply wired and not something you can easily think your way out of.

In practical terms, this means lorazepam can make you reach for snacks more often, eat larger portions, and gravitate toward calorie-dense comfort foods. If you have ever noticed that you eat more or enjoy food more intensely on days you take the medication, that is not your imagination. It is a pharmacological effect.

Metabolic Shifts Behind the Scenes

Beyond appetite, lorazepam may nudge your metabolism in ways that favor fat storage. A study examining the metabolic effects of benzodiazepines during exercise found that taking a benzodiazepine before physical activity led to decreased cortisol and increased insulin levels compared to a placebo, even before exercise began. During the exercise itself, the stress hormones (norepinephrine, epinephrine, cortisol) that normally rise with exertion were significantly blunted under the benzodiazepine condition.

⁴

What does that mean for weight? Insulin is a storage hormone. When insulin levels rise, your body is primed to shuttle glucose into cells and store excess energy as fat. Meanwhile, the blunted cortisol and catecholamine response during activity means your body may burn fewer calories during exercise than it normally would. The net effect is a subtle metabolic environment that favors calorie storage over calorie burning. Individually, these shifts are small on any given day, but compounded over weeks or months of daily use, they could contribute to gradual weight creep.

There is also the sedation factor to consider. Lorazepam is prescribed precisely because it calms the nervous system, and one of its most common side effects is drowsiness. People who feel sedated move less. They may skip workouts, spend more time on the couch, or simply fidget and walk around less throughout the day. That reduction in non-exercise activity thermogenesis, the calories you burn just going about your day, can add up to a meaningful deficit in energy expenditure over time.

When Lorazepam Actually Helps With Weight Restoration

There is an interesting flip side to the appetite-stimulating properties of lorazepam. In people with anorexia nervosa, where extreme anxiety around food is a core barrier to recovery, lorazepam has been used deliberately to help patients eat more. A case series of three adolescents with anorexia found that short-term, low-dose lorazepam given before meals reduced pre-meal anxiety and improved food intake, treatment adherence, and weight restoration. The benefits persisted even after the medication was stopped, and no adverse effects such as sedation, tolerance, or dependence were observed during the brief treatment period.

⁵

This shows that the same appetite-enhancing quality that worries someone trying to maintain their weight can be genuinely therapeutic in a different context. It also reinforces that the appetite effect is real and clinically meaningful, not just anecdotal. If lorazepam can help underweight patients eat enough to gain, it stands to reason that it can push people who are already at a healthy weight or above toward unwanted gain.

How to Manage Weight While Taking Lorazepam

If you are prescribed lorazepam and concerned about weight, the good news is that the mechanisms involved are addressable. You are not fighting some irreversible metabolic reprogramming. You are dealing with an enhanced appetite and a tendency toward lower activity, both of which respond to deliberate countermeasures.

Track your intake early: The palatability effect can sneak up on you. Food journaling for the first few weeks after starting lorazepam helps you spot changes in portion size or snacking frequency before they become habits. You do not need to count every calorie forever, but a brief monitoring period gives you a baseline.
Stock your environment deliberately: Since lorazepam makes food more rewarding, having high-calorie snacks easily accessible is a setup for overconsumption. Keep fruits, vegetables, and other lower-calorie options front and center. The enhanced palatability works on whatever food is available, so making the available options healthier is a simple hedge.
Protect your activity level: Sedation is the side effect most likely to erode your exercise routine. If you notice drowsiness, talk to your prescriber about timing the dose so it interferes least with your active hours. Some people take lorazepam in the evening to manage this. Even low-intensity activities like walking count toward energy expenditure.
Watch for emotional eating patterns: People taking lorazepam for anxiety sometimes develop a loop where residual anxiety triggers eating (because food now feels even more rewarding), which provides temporary relief but leads to guilt and more anxiety. Recognizing this pattern early makes it easier to interrupt.
Discuss duration with your prescriber: Lorazepam is generally intended for short-term use. The longer you take it, the more opportunity there is for cumulative weight effects. If you have been on it for months and weight gain is a concern, your doctor may consider tapering to a non-benzodiazepine alternative for long-term anxiety management.

None of these strategies require radical lifestyle changes. The weight gain associated with lorazepam tends to be gradual rather than dramatic, which means modest, consistent adjustments are usually enough to counteract it.

What Happens to Weight When You Stop

If lorazepam contributes to weight gain while you are taking it, you might expect weight to normalize once you stop. The evidence suggests this is partly true, but the withdrawal period comes with its own appetite disruption. A classic study on long-term benzodiazepine withdrawal found that people coming off these drugs experienced disturbed appetite and noticeable weight loss.

⁶

Animal research paints a more detailed picture. Rats withdrawn from chronic lorazepam showed a clear dose-dependent drop in food intake and body weight, with the effects peaking on the first day of withdrawal. Across every dose level tested, reduced eating and weight loss appeared as consistent withdrawal symptoms, suggesting this is a fundamental rebound effect rather than something that only happens at high doses.

⁷

For someone who gained weight on lorazepam, this rebound appetite suppression might sound like a silver lining, but it is not something to bank on as a weight-loss strategy. The withdrawal period can also bring insomnia, heightened anxiety, and general discomfort that makes healthy eating difficult. And if the weight gain was partly driven by habits formed during treatment, like larger portions or more frequent snacking, those habits do not automatically reverse when the drug leaves your system.

How Lorazepam Compares to Other Psychiatric Medications

To put lorazepam’s weight effects in perspective, it sits in a very different category from the psychiatric medications most notorious for causing weight gain. Certain antipsychotics and some antidepressants can cause gains measured in double-digit pounds over months, driven by powerful effects on histamine, serotonin, and metabolic hormones. Lorazepam’s influence is subtler. Most people taking it for short periods notice little or no change on the scale. The risk increases with longer use, higher doses, and individual susceptibility factors like baseline metabolic health and how sensitive your appetite system is to GABA modulation.

Among the benzodiazepines themselves, there is no strong evidence that lorazepam is worse than its relatives for weight gain. The appetite-stimulating effect appears to be a class-wide property tied to GABA-A receptor activation rather than something unique to lorazepam’s molecular structure. If weight gain has been a problem on lorazepam, switching to a different benzodiazepine is unlikely to solve it. A switch to a different class of medication altogether, such as a selective serotonin reuptake inhibitor for anxiety, might reduce the appetite-enhancement effect, though those drugs carry their own metabolic considerations.

Individual Variation and Who Is Most at Risk

Not everyone who takes lorazepam gains weight, and the individual variation is wide. Several factors influence where you land on the spectrum.

People who are already prone to emotional or stress-related eating before starting lorazepam may be more vulnerable, because the drug amplifies the reward value of food at a time when they are already using food as a coping mechanism. Similarly, people with lower baseline physical activity levels have less buffer to absorb extra calories without gaining weight. If you are sedentary to begin with and lorazepam’s drowsiness makes you even less active, the caloric imbalance tips faster.

Dose and duration matter. Someone taking 0.5 mg as needed for occasional panic attacks faces a very different risk profile than someone on 2 mg daily for months. The FAERS data showing obesity as a signal does not break down by dose, but the animal research on withdrawal, which found dose-dependent effects on food intake and body weight, suggests the appetite impact scales with how much drug is on board.

⁷

Age and metabolism also play a role. Older adults metabolize lorazepam more slowly, which means the drug stays active in the body longer and its effects on appetite and sedation may be more pronounced. This overlaps with the fact that metabolic rate generally declines with age, making any additional caloric intake more likely to result in stored fat.

Why This Side Effect Flies Under the Radar

One reason lorazepam’s weight effects are not more widely discussed is that benzodiazepines are generally prescribed for short-term use. In theory, a two-to-four-week course should not produce meaningful weight change. In practice, many people end up on benzodiazepines for much longer than intended, and the gradual nature of the weight gain makes it easy to attribute to other causes: aging, stress, dietary changes, reduced exercise. By the time someone connects the dots, they may have been on the medication for months.

Another factor is that lorazepam is often prescribed alongside other medications that are themselves associated with weight gain. Someone taking lorazepam for anxiety might also be on an antidepressant or a mood stabilizer. When weight goes up, the lorazepam is rarely the first suspect. The FAERS analysis is useful precisely because it isolates the lorazepam signal from the noise, and the signal it found was strong enough to merit attention.

There is also a cultural dimension. Benzodiazepines have been prescribed since the 1960s, and their side-effect profile is often treated as thoroughly understood. Clinicians may not think to mention weight gain as a possibility because it is not in the labeling, and patients may not think to ask. The gap between what the label says and what real-world data shows is wider than most people assume, and weight is one of the areas where that gap is most apparent.

1
PubMed Central. Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database
2
PubMed. Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes
3
Neuroscience & Biobehavioral Reviews. Benzodiazepines, appetite, and taste palatability
4
PubMed Central. Performance and metabolic effects of benzodiazepine during submaximal exercise
5
ResearchGate / Turkish Journal of Clinical Psychiatry. Lorazepam use in the treatment of pre-meal anxiety of anorexia nervosa: Three adolescent cases
6
British Medical Journal. Withdrawal from long-term benzodiazepine treatment
7
European Neuropsychopharmacology. Tolerance and withdrawal after chronic lorazepam treatment in rats